Ensysce Biosciences, Inc. SEC filings ENSC

Ensysce Biosciences, Inc. has 547 filings in SEC EDGAR's recent list, going back to Oct 3, 2017. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.

Ensysce Biosciences, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Nov 4, 2026 Oct 29, 2026
PRE 14A Preliminary proxy statement Oct 30, 2026 Oct 30, 2026
S-3 Shelf registration Oct 23, 2026 —
8-K/A Amended current report Oct 16, 2026 Aug 5, 2026
8-K Current report
Bylaw or fiscal year change
Sep 29, 2026 Sep 25, 2026
8-K Current report
Other events
Aug 25, 2026 Aug 25, 2026
8-K Current report
Other events
Aug 24, 2026 Aug 24, 2026
D Filing Aug 20, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 18, 2026 —
4 Insider transaction Aug 18, 2026 Apr 23, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
3 Initial insider ownership Aug 10, 2026 Aug 5, 2026
8-K/A Amended current report Aug 6, 2026 Aug 5, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Aug 6, 2026 Aug 5, 2026
8-K Current report
Officer or director change
Jul 15, 2026 Jul 15, 2026
EFFECT Filing Jun 26, 2026 —
S-3 Shelf registration Jun 4, 2026 —
8-K Current report
Listing notice
May 22, 2026 May 22, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 15, 2026 May 15, 2026
S-8 Employee stock plan registration Apr 30, 2026 —
EFFECT Filing Apr 15, 2026 —
CORRESP Letter to the SEC Apr 14, 2026 —
UPLOAD Letter from the SEC Apr 13, 2026 —
S-3 Shelf registration Apr 9, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 8, 2026 Apr 7, 2026
8-K Current report
Officer or director change
Apr 3, 2026 Apr 3, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 30, 2026 Mar 30, 2026
8-K Current report
Officer or director change
Mar 30, 2026 Mar 27, 2026
8-K Current report
Bylaw or fiscal year change
Mar 23, 2026 Mar 23, 2026
8-K Current report
Listing notice
Feb 27, 2026 Feb 27, 2026
8-K Current report
Shareholder vote results
Jan 8, 2026 Jan 8, 2026
DEFA14A Additional proxy material Dec 16, 2025 —
EFFECT Filing Dec 11, 2025 —
CORRESP Letter to the SEC Dec 9, 2025 —
S-3 Shelf registration Dec 2, 2025 —
ARS Annual report to shareholders Dec 2, 2025 Dec 31, 2024
DEF 14A Proxy statement Dec 2, 2025 Dec 2, 2025
PRE 14A Preliminary proxy statement Nov 21, 2025 Nov 21, 2025
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Nov 17, 2025 Nov 17, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 14, 2025 Nov 14, 2025
424B5 Prospectus supplement Nov 14, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 13, 2025 Aug 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2025 —
8-K Current report
Auditor change
Jun 5, 2025 Jun 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
SCHEDULE 13G Ownership over 5% (passive) May 12, 2025 —
EFFECT Filing May 9, 2025 —
CORRESP Letter to the SEC May 9, 2025 —
UPLOAD Letter from the SEC May 9, 2025 —
S-8 Employee stock plan registration May 2, 2025 —
S-3 Shelf registration May 2, 2025 —
D Filing Apr 25, 2025 —
EFFECT Filing Apr 24, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 24, 2025 Apr 23, 2025
EFFECT Filing Apr 23, 2025 —
CORRESP Letter to the SEC Apr 23, 2025 —
CORRESP Letter to the SEC Apr 22, 2025 —
CORRESP Letter to the SEC Apr 22, 2025 —
UPLOAD Letter from the SEC Apr 21, 2025 —
UPLOAD Letter from the SEC Apr 21, 2025 —
S-3 Shelf registration Apr 16, 2025 —
S-3 Shelf registration Apr 16, 2025 —
D Filing Apr 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 3, 2025 —
8-K Current report
Other events
Apr 1, 2025 Apr 1, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 31, 2025 Mar 31, 2025
424B5 Prospectus supplement Mar 31, 2025 —
10-K Annual report Mar 10, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
8-K Current report
Material agreement
Feb 4, 2025 Feb 4, 2025
8-K Current report
Bylaw or fiscal year change
Dec 3, 2024 Dec 3, 2024
8-K Current report
Shareholder vote results
Nov 21, 2024 Nov 21, 2024
DEFA14A Additional proxy material Nov 19, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
SC 13G Ownership over 5% (passive) Nov 6, 2024 —
SC 13G Ownership over 5% (passive) Oct 29, 2024 —
8-K Current report
Bylaw or fiscal year change
Oct 18, 2024 Oct 18, 2024
DEFA14A Additional proxy material Oct 18, 2024 —
DEF 14A Proxy statement Oct 18, 2024 Oct 17, 2024
ARS Annual report to shareholders Oct 18, 2024 Dec 31, 2023
EFFECT Filing Oct 17, 2024 —
EFFECT Filing Oct 15, 2024 —
CORRESP Letter to the SEC Oct 15, 2024 —
UPLOAD Letter from the SEC Oct 15, 2024 —
DEL AM Filing Oct 10, 2024 —
S-3 Shelf registration Oct 9, 2024 —
POS AM Filing Oct 9, 2024 —
PRE 14A Preliminary proxy statement Oct 7, 2024 Oct 7, 2024
D Filing Sep 12, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Aug 30, 2024 Aug 29, 2024
424B5 Prospectus supplement Aug 29, 2024 —
424B5 Prospectus supplement Aug 29, 2024 —
8-K Current report
Listing notice
Aug 23, 2024 Aug 23, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Other events
May 28, 2024 May 28, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Other events
May 9, 2024 May 9, 2024
EFFECT Filing May 1, 2024 —
POS AM Filing Apr 19, 2024 —
EFFECT Filing Apr 5, 2024 —
CORRESP Letter to the SEC Apr 3, 2024 —
8-K Current report
Listing notice
Mar 29, 2024 Mar 29, 2024
S-1/A Amended registration statement Mar 26, 2024 —
8-K Current report
Results of operations
Mar 15, 2024 Mar 15, 2024
10-K Annual report Mar 15, 2024 Dec 31, 2023
D Filing Feb 21, 2024 —
424B3 Prospectus Feb 15, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 14, 2024 Feb 14, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
424B3 Prospectus Feb 14, 2024 —
UPLOAD Letter from the SEC Jan 22, 2024 —
S-1 Registration statement Jan 17, 2024 —
8-K Current report
Other events
Dec 29, 2023 Dec 29, 2023
DEFA14A Additional proxy material Dec 19, 2023 —
8-K Current report
Other events
Dec 19, 2023 Dec 19, 2023
RW Filing Nov 30, 2023 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Nov 29, 2023 Nov 29, 2023
EFFECT Filing Nov 21, 2023 —
CORRESP Letter to the SEC Nov 20, 2023 —
S-1/A Amended registration statement Nov 17, 2023 —
8-K Current report
Listing notice
Nov 17, 2023 Nov 17, 2023
UPLOAD Letter from the SEC Nov 17, 2023 —
DEFA14A Additional proxy material Nov 13, 2023 —
DEF 14A Proxy statement Nov 13, 2023 Nov 9, 2023
S-1 Registration statement Nov 9, 2023 —
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
PRE 14A Preliminary proxy statement Oct 30, 2023 Oct 30, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Oct 24, 2023 Oct 24, 2023
S-8 Employee stock plan registration Oct 20, 2023 —
8-K Current report
Shareholder vote results
Aug 28, 2023 Aug 28, 2023
8-K Current report
Results of operations
Aug 11, 2023 Aug 11, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
SC 13D/A Amended ownership over 5% (active) Jul 18, 2023 —
DEFA14A Additional proxy material Jul 14, 2023 —
DEF 14A Proxy statement Jul 14, 2023 Jul 13, 2023
8-K Current report
Other events
Jun 14, 2023 Jun 13, 2023
8-K Current report
Other events
Jun 2, 2023 Jun 2, 2023
POS EX Filing May 17, 2023 —
AW Filing May 17, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Material agreement, Other events
May 15, 2023 May 15, 2023
424B3 Prospectus May 12, 2023 —
424B3 Prospectus May 12, 2023 —
424B3 Prospectus May 12, 2023 —
424B3 Prospectus May 12, 2023 —
POS AM Filing May 12, 2023 —
EFFECT Filing May 9, 2023 —
CORRESP Letter to the SEC May 9, 2023 —
CORRESP Letter to the SEC May 9, 2023 —
S-1/A Amended registration statement May 9, 2023 —
S-1/A Amended registration statement May 8, 2023 —
UPLOAD Letter from the SEC May 4, 2023 —
S-1 Registration statement Apr 28, 2023 —
8-K Current report
Auditor change
Apr 10, 2023 Apr 10, 2023
8-A12G/A Filing Mar 31, 2023 —
8-K Current report
Results of operations
Mar 31, 2023 Mar 30, 2023
10-K Annual report Mar 30, 2023 Dec 31, 2022
8-K Current report
Bylaw or fiscal year change
Mar 30, 2023 Mar 30, 2023
8-K Current report
Shareholder vote results
Mar 24, 2023 Mar 24, 2023
4 Insider transaction Mar 6, 2023 Mar 2, 2023
4 Insider transaction Mar 2, 2023 Feb 28, 2023
D Filing Mar 1, 2023 —
DEF 14A Proxy statement Feb 24, 2023 Feb 23, 2023
S-3/A Filing Feb 16, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
PRE 14A Preliminary proxy statement Feb 13, 2023 Feb 13, 2023
8-A12G/A Filing Feb 7, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Feb 7, 2023 Feb 7, 2023
SC 13G Ownership over 5% (passive) Feb 7, 2023 —
424B5 Prospectus supplement Feb 6, 2023 —
4 Insider transaction Feb 1, 2023 Dec 9, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Feb 1, 2023 Feb 1, 2023
8-A12G Filing Feb 1, 2023 —
8-K Current report
Listing notice
Jan 31, 2023 Jan 30, 2023
S-3 Shelf registration Jan 31, 2023 —
8-K Current report
Other events
Jan 19, 2023 Jan 18, 2023
EFFECT Filing Jan 17, 2023 —
CORRESP Letter to the SEC Jan 13, 2023 —
UPLOAD Letter from the SEC Jan 13, 2023 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Jan 13, 2023 Jan 13, 2023
S-3 Shelf registration Jan 9, 2023 —
424B4 Prospectus Jan 3, 2023 —
EFFECT Filing Dec 29, 2022 —
CORRESP Letter to the SEC Dec 27, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ENSC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1716947
Former names
Leisure Acquisition Corp. (until Jun 30, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.